[1]郭元红,陈伟庆,房殿亮.Runx3基因对HepG2细胞顺铂耐药性的影响[J].第三军医大学学报,2012,34(09):813-816.
 Guo Yuanhong,Chen Weiqing,Fang Dianliang.Runx3 improves chemosensitivity of hepatocellular carcinoma cells HepG2 to cisplatin[J].J Third Mil Med Univ,2012,34(09):813-816.
点击复制

Runx3基因对HepG2细胞顺铂耐药性的影响(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
34卷
期数:
2012年第09期
页码:
813-816
栏目:
论著
出版日期:
2012-05-15

文章信息/Info

Title:
Runx3 improves chemosensitivity of hepatocellular carcinoma cells HepG2 to cisplatin
作者:
郭元红陈伟庆房殿亮
重庆医科大学附属第二医院消化内科
Author(s):
Guo Yuanhong Chen Weiqing Fang Dianliang
Department of Digestive Diseases, Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China
关键词:
Runx3耐药肝癌DNA甲基化细胞周期RNA干扰
Keywords:
Runx3 drug resistance hepatocellular carcinoma DNA methylation cell cycle RNA interference
分类号:
R363.25; R735.7; R966
文献标志码:
A
摘要:
目的       探讨Runx3基因对HepG2细胞耐药性的影响及可能机制。      方法       取在1.6 μg/ml顺铂(CDDP)下生长良好的HepG2耐药细胞(HepG2/CDDP-1.6),建立耐药HepG2/CDDP的动态变化模型HepG2/CDDP/2.0,并予以甲基转移酶抑制剂5-氮-2′-脱氧胞苷(5-Aza-CdR)处理;将Runx3-shRNA表达载体转染HepG2/ CDDP-1.6细胞,RT-PCR检测处理及转染前后细胞Runx3 mRNA的表达。MTT法检测细胞的增殖活性,流式细胞仪分析细胞周期,Hoechst 33258检测凋亡,Western blot检测P-gp表达的变化。      结果       在动态变化模型中随CDDP诱导时间的延长,Runx3 mRNA的表达逐渐降低。5-Aza-CdR处理后Runx3 mRNA的表达增加,细胞生长受到明显抑制,S期细胞逐渐增加,凋亡细胞明显增多,细胞内P-gp的表达减少。转染Runx3-shRNA载体后HepG2/CDDP-1.6细胞对CDDP的耐受性增强,G1期细胞增加,P-gp的表达增加。      结论        Runx3基因的表达可抑制HepG2/CDDP耐药的形成,提高HepG2/CDDP细胞对化疗药物的敏感性。
Abstract:
Objective       To determine the effect of Runx3 in drug resistance against hepatocellular carcinoma cells.       Methods       HepG2/cisplatin(CDDP) kinetic anti-cancer drug resistance model was constructed using anti-cancer drug inducing method and treated with 5-Aza-2′-deoxycytidine (5-Aza-CdR) for different periods of time. Runx3-shRNA expression vectors were transfected into drug-resistant HepG2 cells. Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect Runx3 mRNA expression before and after transfection. Cell viability was evaluated by MTT assay, and apoptosis was analyzed using Hoechst 33258. Flow cytometry (FCM) was used to detect the cell cycle distribution, and Western blotting was used to measure the expression levels of P-gp and Runx3.       Results       The expression of Runx3 mRNA was decreased with the increasing drug resistance against HepG2 cells. However, it was increased gradually after treated with 5-Aza-CdR, and cell proliferation was inhibited obviously. The cells at S phase and apoptotic cells were increased. Also, 5-Aza-CdR resulted in a decrease of P-gp. Down-regulation of Runx3 in drug-resistant HepG2 cells promoted the cell proliferation, the cell cycle arrested at G1, and increased expression of P-gp, which indicated that it inhibited the drug sensitivity.       Conclusion       Runx3 may play an inhibitive role in drug resistance, and up-regulation of Runx3 might prove cancer cells more sensitive to chemotherapy.

相似文献/References:

[1]吴国明,钱桂生.晚期非小细胞肺癌EGFR-TKIs治疗的耐药机制研究——挑战中蕴含新的曙光[J].第三军医大学学报,2012,34(20):2031.
 Wu Guoming,Qian Guisheng.Drug resistance of epidermal growth factor receptor-tyrosine kinase inhibitors in treatment of advanced non-small cell lung cancer—A new dawn in challenge[J].J Third Mil Med Univ,2012,34(09):2031.
[2]祝冰晶,王宇亮,罗虎,等.CA916798基因通过PI3K/AKT通路参与肺癌顺铂耐药[J].第三军医大学学报,2013,35(07):618.
 Zhu Bingjing,Wang Yuliang,Luo Hu,et al.CA916798 gene is involved in cisplatin resistance in human lung cancer through PI3K/AKT pathway[J].J Third Mil Med Univ,2013,35(09):618.
[3]周艳,姜军,张毅,等.雌激素受体β及其剪切变异体表达与雌激素受体阻滞剂治疗耐药的关系[J].第三军医大学学报,2007,29(20):1999.
 ZHOU Yan,JIANG Jun,ZHANG Yi,et al.Relationship of estrogen receptor-beta and its isoform expressions with tamoxifen resistance in human breast cancer[J].J Third Mil Med Univ,2007,29(09):1999.
[4]向征,张才全,汤为学.TSG101-siRNA对肝癌耐药细胞株QGY/CDDP的逆转作用[J].第三军医大学学报,2008,30(02):170.
 XIANG Zheng,ZHANG Cai-quan,TANG Wei-xue.Effect of tumor susceptibitity gene 101-siRNA eukaryotic expression vector and cisplatin on proliferation of QGY/CDDP[J].J Third Mil Med Univ,2008,30(09):170.
[5]林辉,刘洁,陈林,等.重庆市2003-2006年肺结核病耐药情况分析[J].第三军医大学学报,2008,30(12):1183.
 LIN Hui,LIU Jie,CHEN Lin,et al.Drug resistance of tuberculosis from 2003 to 2006 in Chongqing[J].J Third Mil Med Univ,2008,30(09):1183.
[6]陈幸华,张诚,张曦,等.人淋巴细胞白血病细胞黏附介导耐药模型构建初探[J].第三军医大学学报,2006,28(23):2336.
[7]房殿亮,陈伟庆.p15基因干扰对肝癌耐药的影响[J].第三军医大学学报,2011,33(16):1695.
 Fang Dianliang,Chen Weiqing.Influence of siRNA-mediated p15 silencing on CDDP resistance in drug-resistant human hepatoma cell line HepG2/CDDP/2.0[J].J Third Mil Med Univ,2011,33(09):1695.
[8]何建明,江恒,陈克力,等.结肠癌HT29多细胞球的培养及其结构与生物学特性的观察[J].第三军医大学学报,2010,32(16):1691.
 He Jianming,Jiang Heng,Chen Keli,et al.Structure and biological features of multicellular spheroids of colon cancer HT29 cells[J].J Third Mil Med Univ,2010,32(09):1691.
[9]舒丹,曾飚,何华,等.hMLH1基因对人卵巢癌耐药细胞株顺铂敏感性的研究[J].第三军医大学学报,2010,32(23):2527.
 Shu Dan,Zeng Biao,He Hua,et al.Effect of hMLH1 gene on cisplatin sensitivity of drug-resistant human ovarian cancer cell line[J].J Third Mil Med Univ,2010,32(09):2527.
[10]侯春阳,李梅.脑型肺吸虫病38例临床分析[J].第三军医大学学报,2011,33(02):214.

更新日期/Last Update: 2012-05-07